DOSSIER · 13F Holders · Q1 2026
RVPH
REVIVA PHARMACEU
5 institutions still hold REVIVA PHARMACEU as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 76152G209·5 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
5 institutions reported RVPH in Q1 2026. GSA CAPITAL PARTNERS LLP leads at 73.7% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.